Clinical Trial

A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine

Completed Phase 4
View on ClinicalTrials.gov →
Summary
This prospective, single-arm feasibility study will evaluate postoperative pain control, opioid use, and early recovery outcomes in adult patients undergoing elective outpatient facial plastic surgery who receive suzetrigine as part of their standard postoperative analgesic regimen.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-21.
Status change: Not Yet Recruiting → Completed 2026-04-27
Trial Details
NCT Number NCT07257133
Lead Sponsor Mayo Clinic
Conditions Post Operative Pain
Enrollment 100 participants
Start Date 2025-10-20
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-01